Waddell & Reed Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$72.6M Sell
1,613,947
-536,823
-25% -$24.1M 0.15% 178
2020
Q4
$122M Hold
2,150,770
0.26% 109
2020
Q3
$102M Sell
2,150,770
-15,555
-0.7% -$738K 0.24% 113
2020
Q2
$128M Buy
2,166,325
+14
+0% +$825 0.33% 81
2020
Q1
$102M Sell
2,166,311
-23,826
-1% -$1.13M 0.33% 83
2019
Q4
$132M Sell
2,190,137
-989,941
-31% -$59.8M 0.33% 83
2019
Q3
$191M Buy
3,180,078
+19
+0% +$1.14K 0.49% 48
2019
Q2
$204M Sell
3,180,059
-182,247
-5% -$11.7M 0.51% 43
2019
Q1
$273M Sell
3,362,306
-135,756
-4% -$11M 0.68% 33
2018
Q4
$189M Sell
3,498,062
-334,649
-9% -$18.1M 0.54% 43
2018
Q3
$198M Sell
3,832,711
-697,389
-15% -$36M 0.44% 56
2018
Q2
$189M Hold
4,530,100
0.44% 56
2018
Q1
$200M Hold
4,530,100
0.45% 57
2017
Q4
$228M Sell
4,530,100
-12,000
-0.3% -$604K 0.51% 49
2017
Q3
$230M Sell
4,542,100
-598,100
-12% -$30.3M 0.51% 52
2017
Q2
$261M Sell
5,140,200
-10,400
-0.2% -$529K 0.58% 44
2017
Q1
$207M Sell
5,150,600
-592,200
-10% -$23.8M 0.44% 66
2016
Q4
$275M Sell
5,742,800
-70,600
-1% -$3.38M 0.6% 45
2016
Q3
$213M Sell
5,813,400
-135,800
-2% -$4.98M 0.44% 63
2016
Q2
$139M Buy
5,949,200
+148,100
+3% +$3.45M 0.29% 94
2016
Q1
$235M Buy
5,801,100
+30,800
+0.5% +$1.25M 0.44% 65
2015
Q4
$357M Hold
5,770,300
0.58% 51
2015
Q3
$233M Buy
5,770,300
+1,000
+0% +$40.4K 0.38% 71
2015
Q2
$332M Buy
5,769,300
+318,900
+6% +$18.4M 0.47% 66
2015
Q1
$347M Hold
5,450,400
0.48% 62
2014
Q4
$337M Sell
5,450,400
-43,700
-0.8% -$2.7M 0.47% 65
2014
Q3
$213M Buy
5,494,100
+130,300
+2% +$5.06M 0.3% 90
2014
Q2
$185M Buy
5,363,800
+48,900
+0.9% +$1.68M 0.27% 98
2014
Q1
$230M Buy
5,314,900
+574,300
+12% +$24.8M 0.35% 77
2013
Q4
$189M Buy
4,740,600
+506,200
+12% +$20.2M 0.3% 90
2013
Q3
$159M Buy
4,234,400
+357,100
+9% +$13.4M 0.3% 89
2013
Q2
$104M Buy
+3,877,300
New +$104M 0.22% 113